Company Profiles

driven by the PitchBook Platform

A&G Pharmaceutical

A&G Pharmaceutical
2000 FOUNDED
PRIVATE STATUS
11-50 EMPLOYEES
Grant LATEST DEAL TYPE
$3.34M LATEST DEAL AMOUNT
$5.4M TOTAL AMOUNT RAISED
Description

Developer of personalized medicine products designed to treat cancer and other human diseases. The company's personalized medicine products use antibodies to selectively recognize and latch on to the specific cell-surface bio-markers that distinguish diseased cells from normal cells, enabling cancer patients to access personalized care facilities.

Website:
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Other Pharmaceuticals and Biotechnology
Primary Office
9130 Red Branch Road
Suite U
Columbia, MD 21045
United States

+1 (410) 884-4100
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore A&G Pharmaceutical’s full profile, request a free trial.

A&G Pharmaceutical Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
12. Grant 01-Jan-2017 $3.34M $5.4M Completed Generating Revenue
11. Accelerator/Incubator 26-Feb-2014 00.00 Completed Generating Revenue
10. Grant 06-May-2013 00000 00.00 Completed Generating Revenue
9. Grant 28-Sep-2010 00.000 00.00 Completed Generating Revenue
8. Later Stage VC (Series B) 27-Apr-2010 00000 00.00 000.00 Completed Generating Revenue
7. Accelerator/Incubator 19-Jun-2009 00.00 Completed Generating Revenue
6. Accelerator/Incubator 01-Jan-2009 00.00 Completed Generating Revenue
5. Grant 14-Dec-2007 00000 00.00 Completed Generating Revenue
4. Later Stage VC (Series B) 04-Jan-2007 00.00 00.00 000.00 Completed Generating Revenue
3. Early Stage VC (Series A) 08-Sep-2005 00.000 00.00 00.000 Completed Startup
2. Convertible Debt 24-Mar-2004 $750k $1.05M Completed Startup
1. Seed Round 24-Apr-2002 $300k $300k Completed Startup
To view this company’s complete deal history including valuation and funding request access »

A&G Pharmaceutical Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series B 00,000 00.000000 00 00.00 00.00 00 00.00 0.000
Series A 0,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
To view this company’s complete Cap Table request access »

A&G Pharmaceutical Investors (17)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
ASM Resources Venture Capital Minority 000 0000 000000 0
Avon Foundation for Women Other 000 0000 000000 0
Celltrion Other Minority 000 0000 000000 0
Crocker Capital Venture Capital Minority 000 0000 000000 0
ETC Baltimore Accelerator/Incubator Minority 000 0000 000000 0
You’re viewing 5 of 17 investors. Get the full list »

A&G Pharmaceutical Executive Team (6)

Name Title Board
Seat
Contact
Info
Ginette Serrero Ph.D Co-Founder, Chief Executive Officer & Board Member
Michael Keefe Chief Operating Officer
David Hicks Director, Product Development
Jun Hayashi Ph.D Co-Founder & Vice President, Research & Development
Gordon Sato Ph.D Co-Founder, Chairman and Scientific Advisor
You’re viewing 5 of 6 executives. Get the full list »

A&G Pharmaceutical Board Members (5)

Name Representing Role Since Contact
Info
Ginette Serrero Ph.D A&G Pharmaceutical Co-Founder, Chief Executive Officer & Board Member 000 0000
Gordon Sato Ph.D A&G Pharmaceutical Co-Founder, Chairman and Scientific Advisor 000 0000
Lars Hanan BroadOak Capital Partners Board Member 000 0000
SeungSuh Hong Celltrion Board Member 000 0000
Tom Hancock New England Partners Board Member 000 0000

You’re viewing 5 of 5 board members.